← All trials
NCT04667819
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2020
- Primary completion
- Dec 31, 2021
- Completion date
- Mar 31, 2022
- First posted
- Dec 16, 2020
- Last posted
- Dec 16, 2020
- Enrollment
- 20
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Tianjin Eye HospitalLead sponsor
- Tianjin Eye HospitalStudy director
- Tianjin UniversityOverall official - principal investigator
- Tianjin UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.